著者

炭 昌樹 長谷川 千晶 森井 博朗 星野 伸夫 奥貫 裕美 金本 賢枝 堀江 美弥 岡本 陽香 藪田 直希 松田 雅史 神谷 貴樹 須藤 正朝 増田 恭子 岩下 由梨 松田 佳織 本岡 芳子 平 大樹 森田 真也 寺田 智祐

出版者

公益社団法人 日本薬学会

雑誌

YAKUGAKU ZASSHI (ISSN:00316903)

巻号頁・発行日

vol.138, no.5, pp.715-722, 2018 (Released:2018-05-01)

参考文献数

10

被引用文献数

1

---

The importance of community-based care systems has increased due to the highly aging population and diversity of disease. To enhance the cooperation among healthcare professionals in community-based care systems, a two-day on-site training program for community pharmacists based on a multidisciplinary team approach was conducted at the Medical Science Hospital of Shiga University from April 2015 to March 2017. There were two professional courses in this training program: the palliative care course and nutrition support course. Both courses consisted of common pharmaceutical care training as follows: regional cooperation among healthcare professionals, pharmacist's clinical activities in the ward, pressure ulcer care, infection control, and aseptic technique for parenteral solutions. Each course was limited to 2 participants. A questionnaire was given to participants in the training program. Seventy-five pharmacists participated in the training and all of them answered the questionnaire. According to the questionnaire, 86% of participants felt that 2 days was an appropriate term for the training program. Positive answers regarding the content of each program and overall satisfaction were given by 100% and 99% of the participants, respectively. In the categorical classification of free comments regarding the expected change in pharmacy practice after the training, both “support for patients under nutritional treatment” and “cooperation with other medical staff” were answered by 24 participants. These results suggested that the 2-day on-site training for community pharmacists facilitated cooperation among healthcare professionals in the community.

著者

藪田 直希

出版者

公益社団法人 日本薬学会

雑誌

ファルマシア (ISSN:00148601)

巻号頁・発行日

vol.50, no.6, pp.577, 2014 (Released:2016-07-02)

参考文献数

4

---

シスプラチン(cisplatin:CDDP)は,多くの固形がんに用いられる抗腫瘍性白金錯体だが,腎障害によって減量や休薬を余儀なくされる.代表的な腎障害防止策である輸液による水分負荷を行っても,3分の1の患者で腎障害が起こることが知られており,CDDPの腎毒性軽減のための新たな対策が望まれている.なお,本稿は下記の文献に基づいて,その研究成果を紹介するものである.1) Filipski K. K. et al., Clin. Pharmcol. Ther., 86, 396-402 (2009).2) Ciarimboli G. et al., Am. J. Pathol., 176, 1169-1180 (2010).3) Sprowl J. A. et al., Clin. Pharmcol. Ther., 94, 585-592 (2013).4) Franke R. M. et al., Clin. Cancer. Res., 16, 4198-4206 (2010).